Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3.
Eskelund CW, Dimopoulos K, Kolstad A, Glimelius I, Räty R, Gjerdrum LMR, Sonnevi K, Josefsson P, Nilsson-Ehle H, Bentzen HHN, Fagerli UM, Kuittinen O, Haaber J, Niemann CU, Pedersen LB, Larsen MT, Geisler CH, Hutchings M, Jerkeman M, Grønbæk K.
Eskelund CW, et al. Among authors: haaber j.
Hemasphere. 2020 Dec 21;5(1):e510. doi: 10.1097/HS9.0000000000000510. eCollection 2021 Jan.
Hemasphere. 2020.
PMID: 33364550
Free PMC article.